No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID-19 disease,Clinical & Translational Immunology

当前位置： X-MOL 学术 › Clin. Transl. Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID-19 disease
Clinical & Translational Immunology ( IF 4.6 ) Pub Date : 2021-06-30 , DOI: 10.1002/cti2.1308
José Alquicira-Hernandez _{1,

2} , Joseph E Powell _{1,

3} , Tri Giang Phan _{1,

4}

Affiliation

A recent single-cell RNA sequencing study by Wilk et al. suggested that plasmablasts can transdifferentiate into ‘developing neutrophils’ in patients with severe COVID-19 disease. We explore the evidence for this.

中文翻译：